Drug Type Small molecule drug |
Synonyms BMS 480404, BMS-480404, BMS480404 |
Target |
Action inhibitors |
Mechanism FABP5 inhibitors(Fatty acid binding protein 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H18Cl2O5 |
InChIKeyNCWQPARYSYJFNI-FQEVSTJZSA-N |
CAS Registry533889-36-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metabolic Diseases | Preclinical | United States | - |





